HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M400501-JLR200v1 46/8/1615    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodriguez-Agudo, D. Articles by Pandak, W. M. Search for Related Content PubMed PubMed Citation Articles by Rodriguez-Agudo, D. Articles by Pandak, W. M. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 46, 1615-1623, August 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

Human StarD5, a cytosolic StAR-related lipid binding protein

Daniel Rodriguez-Agudo^*, Shunlin Ren^*, Phillip B. Hylemon, Kaye Redford^*, Ramesh Natarajan^*, Antonio Del Castillo, Gregorio Gil and William M. Pandak^1,*

^* Departments of Medicine, Veterans Affairs Medical Center and Virginia Commonwealth University, Richmond, VA
Microbiology/Immunology, Veterans Affairs Medical Center and Virginia Commonwealth University, Richmond, VA
Biochemistry, Veterans Affairs Medical Center and Virginia Commonwealth University, Richmond, VA

Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.M400501-JLR200

¹ To whom correspondence should be addressed. e-mail: wmpandak{at}hsc.vcu.edu

Recently identified StarD5 belongs to the StarD4 subfamily, a subfamily of steroidogenic acute regulatory related lipid transfer (START) domain proteins that includes StarD4 and StarD6, proteins whose functions remain unknown. The objective of this study was to confirm StarD5's protein localization and sterol binding capabilities as measures to pursue function. Using rabbit polyclonal antibody against newly purified human histidine-tagged/StarD5 protein, StarD5 was detected in human liver. In parallel studies, increased expression of StarD5 in primary hepatocytes led to a marked increase in microsomal free cholesterol. Cell fractionation studies demonstrated StarD5 protein in liver cytosolic fractions only, suggesting StarD5 as a directional cytosolic sterol carrier. Supportive in vitro binding assays demonstrated a concentration-dependent binding of cholesterol by StarD5 similar to that of the cholesterol binding START domain protein StarD1. In contrast to selective cholesterol binding by StarD1, StarD5 bound the potent regulatory oxysterol, 25-hydroxycholesterol, in a concentration-dependent manner. StarD5 binding appeared selective for cholesterol and 25-hydroxycholesterol, as no binding was observed for other tested sterols.

The ability of StarD5 to bind not only cholesterol but also 25-hydroxycholesterol, a potent inflammatory mediator and regulatory oxysterol, raises basic fundamental questions about StarD5's role in the maintenance of cellular cholesterol homeostasis.

Supplementary key words liver • cholesterol • metabolism • steroidogenic acute regulatory related lipid transfer • cholesterol transporter

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Rodriguez-Agudo, S. Ren, E. Wong, D. Marques, K. Redford, G. Gil, P. Hylemon, and W. M. Pandak Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation J. Lipid Res., July 1, 2008; 49(7): 1409 - 1419. [Abstract] [Full Text] [PDF]

				W. L. Miller StAR Search--What We Know about How the Steroidogenic Acute Regulatory Protein Mediates Mitochondrial Cholesterol Import Mol. Endocrinol., March 1, 2007; 21(3): 589 - 601. [Abstract] [Full Text] [PDF]

				M. Murcia, J. D. Faraldo-Gomez, F. R. Maxfield, and B. Roux Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol J. Lipid Res., December 1, 2006; 47(12): 2614 - 2630. [Abstract] [Full Text] [PDF]

				W.-J. Wang, J. M. Baez, R. Maurer, H. M. Dansky, and D. E. Cohen Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice J. Lipid Res., November 1, 2006; 47(11): 2400 - 2407. [Abstract] [Full Text] [PDF]

				E. Ikonen Mechanisms for cellular cholesterol transport: defects and human disease. Physiol Rev, October 1, 2006; 86(4): 1237 - 1261. [Abstract] [Full Text] [PDF]

				D. Rodriguez-Agudo, S. Ren, P. B. Hylemon, R. Montanez, K. Redford, R. Natarajan, M. A. Medina, G. Gil, and W. M. Pandak Localization of StarD5 cholesterol binding protein J. Lipid Res., June 1, 2006; 47(6): 1168 - 1175. [Abstract] [Full Text] [PDF]

				S. Ren, P. Hylemon, Z.-P. Zhang, D. Rodriguez-Agudo, D. Marques, X. Li, H. Zhou, G. Gil, and W. M. Pandak Identification of a novel sulfonated oxysterol, 5-cholesten-3{beta},25-diol 3-sulfonate, in hepatocyte nuclei and mitochondria J. Lipid Res., May 1, 2006; 47(5): 1081 - 1090. [Abstract] [Full Text] [PDF]